July 9, 2020 / 10:37 PM / a month ago

BRIEF-U.S. FDA Approves Expanded BOTOX Label For The Treatment Of Pediatric Patients With Spasticity

July 9 (Reuters) - Abbvie Inc:

* FDA APPROVES EXPANDED BOTOX® (ONABOTULINUMTOXINA) LABEL FOR THE TREATMENT OF PEDIATRIC PATIENTS WITH SPASTICITY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below